| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000002711 |
| Receipt No. | R000003293 |
| Official scientific title of the study | Randamized trial to evaluate the effects of splint therapy for temporomandibular disorders. |
| Date of disclosure of the study information | 2009/11/27 |
| Last modified on | 2016/05/24 (Ver. 11) |
| Basic information | ||
| Official scientific title of the study | Randamized trial to evaluate the effects of splint therapy for temporomandibular disorders.
|
|
| Title of the study (Brief title) | Effects of the splint therapy for TMD. | |
| Region |
|
|
| Condition | ||
| Condition | Temporomandibular-disorders | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Clarify the effectiveness of the splint therapy for TMD treatment
|
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II,III |
| Assessment | |
| Primary outcomes | Five time evaluation are done after the insertion of the splint. Recording out come are the mouth opeing distance(mm),the pain and TMJ noize with NRS(numerical rating scale) |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Sprint using
Jaw exercise habit-control educational guidance Evaluation of every 2weeks for 12 weeks |
|
| Interventions/Control_2 | Jaw exercise
habit-control educational guidance Evaluation of every 2weeks for 12 weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | TMD patients having head-neck &TMJ pain, or TMJ noize, or Jaw-opening limitation. | |||
| Key exclusion criteria | Patients rerationg to psychogenic problme. Patients didn't accepted to be participant | |||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiro Nagata |
| Organization | The Nippon Dental university, Niigata hospital |
| Division name | Comprehensive Dental Care |
| Address | 1-8 hamaura-cho, Niigata-city,Niigata-prefecture |
| TEL | 025-267-1500 |
| nagata@ngt.ndu.ac.jp | |
| Public contact | |
| Name of contact person | Kazuhiro Nagata |
| Organization | The Nippon Dental university, Niigata hospital |
| Division name | TMD clinic |
| Address | 1-8 hamaura-cho, Niigata-city,Niigata-prefecture |
| TEL | 025-267-1500 |
| Homepage URL | |
| nagata@ngt.ndu.ac.jp | |
| Sponsor | |
| Institute | The Nippon Dental university, Niigata hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | The Nippon Dental university, Niigata hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Nothing |
| Name of secondary funder(s) | Nothing |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 日本歯科大学新潟病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | http://onlinelibrary.wiley.com/doi/10.1111/joor.12332/full |
| Results | All three parameters significantly decreased over time in both groups. However, there were no significant differences between the two treatment groups in the total comparison or subgroup analyses; an exception was the group with degenerative joint disease. No significant difference between the NS and NS+S treatment approaches was revealed in this study. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003293 |